Paper36949176
Bioinformatics-based investigation on the genetic influence between SARS-CoV-2 infections and idiopathic pulmonary fibrosis (IPF) diseases, and drug repurposing.
Islam MA and 9 others. Sci Rep, 2023. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Bioinformatics-based investigation on the genetic influence between SARS-CoV-2 infections and idiopathic pulmonary fibrosis (IPF) diseases, and drug repurposing. Papers, record 36949176. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36949176
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Bioinformatics-based investigation on the genetic influence between SARS-CoV-2 infections and idiopathic pulmonary fibrosis (IPF) diseases, and drug repurposing.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| COVID-19 | Major topic |
| Idiopathic Pulmonary Fibrosis | Major topic |
| Humans | |
| SARS-CoV-2 | |
| Molecular Docking Simulation | |
| Drug Repositioning | |
| Computational Biology |
Source PubMed
References156
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33784499 | Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replication. | Cell Rep | 2021 | https://conductscience.org/library/papers/33784499 | PubMed |
| 2 | 19910308 | edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. | Bioinformatics | 2010 | https://conductscience.org/library/papers/19910308 | PubMed |
| 3 | 33611340 | Identification of biomarkers and pathways for the SARS-CoV-2 infections that make complexities in pulmonary arterial hypertension patients. | Brief Bioinform | 2021 | https://conductscience.org/library/papers/33611340 | PubMed |
| 4 | 30371825 | PubChem 2019 update: improved access to chemical data. | Nucleic Acids Res | 2019 | https://conductscience.org/library/papers/30371825 | PubMed |
| 5 | 14960460 | Functional topology in a network of protein interactions. | Bioinformatics | 2004 | https://conductscience.org/library/papers/14960460 | PubMed |
| 6 | 24523015 | Recent advances in understanding the pathogenesis of scleroderma-interstitial lung disease. | Curr Rheumatol Rep | 2014 | https://conductscience.org/library/papers/24523015 | PubMed |
| 7 | 32292689 | Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. | Acta Pharm Sin B | 2020 | https://conductscience.org/library/papers/32292689 | PubMed |
| 8 | 34938107 | Exploring the Potential Targets and Mechanisms of Huang Lian Jie Du Decoction in the Treatment of Coronavirus Disease 2019 Based on Network Pharmacology. | Int J Gen Med | 2021 | https://conductscience.org/library/papers/34938107 | PubMed |
| 9 | 33228475 | Computational gene expression profiling in the exploration of biomarkers, non-coding functional RNAs and drug perturbagens for COVID-19. | J Biomol Struct Dyn | 2022 | https://conductscience.org/library/papers/33228475 | PubMed |
| 10 | 35221679 | Functional Roles and Targets of COVID-19 in Blood Cells Determined Using Bioinformatics Analyses. | Bioinform Biol Insights | 2022 | https://conductscience.org/library/papers/35221679 | PubMed |
| 11 | 32366720 | Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs. | Antimicrob Agents Chemother | 2020 | https://conductscience.org/library/papers/32366720 | PubMed |
| 12 | 32661494 | Computational View toward the Inhibition of SARS-CoV-2 Spike Glycoprotein and the 3CL Protease. | Computation (Basel) | 2020 | https://conductscience.org/library/papers/32661494 | PubMed |
| 13 | 34075346 | Simeprevir Potently Suppresses SARS-CoV-2 Replication and Synergizes with Remdesivir. | ACS Cent Sci | 2021 | https://conductscience.org/library/papers/34075346 | PubMed |
| 14 | 32838660 | Structure-based drug repurposing for targeting Nsp9 replicase and spike proteins of severe acute respiratory syndrome coronavirus 2. | J Biomol Struct Dyn | 2022 | https://conductscience.org/library/papers/32838660 | PubMed |
| 15 | 35185890 | Immune Response Is Key to Genetic Mechanisms of SARS-CoV-2 Infection With Psychiatric Disorders Based on Differential Gene Expression Pattern Analysis. | Front Immunol | 2022 | https://conductscience.org/library/papers/35185890 | PubMed |
| 16 | 29156006 | DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA-gene interactions. | Nucleic Acids Res | 2018 | https://conductscience.org/library/papers/29156006 | PubMed |
| 17 | 25521941 | cytoHubba: identifying hub objects and sub-networks from complex interactome. | BMC Syst Biol | 2014 | https://conductscience.org/library/papers/25521941 | PubMed |
| 18 | 31986257 | A novel coronavirus outbreak of global health concern. | Lancet | 2020 | https://conductscience.org/library/papers/31986257 | PubMed |
| 19 | 33008942 | Inflammation and intussusceptive angiogenesis in COVID-19: everything in and out of flow. | Eur Respir J | 2020 | https://conductscience.org/library/papers/33008942 | PubMed |
| 20 | 15286810 | Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. | J Clin Invest | 2004 | https://conductscience.org/library/papers/15286810 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40370100 | In-silico discovery of type-2 diabetes-causing host key genes that are associated with the complexity of monkeypox and repurposing common drugs. | Brief Bioinform | 2025 | https://conductscience.org/library/papers/40370100 | PubMed |
| 39902252 | MACROLACTONES AND MACROLIDES FROM PLANT ENDOPHYTIC FUNGI, CHEMICAL SCAFFOLDS, BIOLOGICAL ACTIVITIES AND SPECTROSCOPY: A COMPREHENSIVE REVIEW. | Bull Pharm Sci | 2024 | https://conductscience.org/library/papers/39902252 | PubMed |
| 39701599 | CDCM: a correlation-dependent connectivity map approach to rapidly screen drugs during outbreaks of infectious diseases. | Brief Bioinform | 2024 | https://conductscience.org/library/papers/39701599 | PubMed |
| 39585882 | Exploring bacterial key genes and therapeutic agents for breast cancer among the Ghanaian female population: Insights from In Silico analyses. | PLoS One | 2024 | https://conductscience.org/library/papers/39585882 | PubMed |
| 39528802 | Discovery of key molecular signatures for diagnosis and therapies of glioblastoma by combining supervised and unsupervised learning approaches. | Sci Rep | 2024 | https://conductscience.org/library/papers/39528802 | PubMed |
| 39160196 | Bioinformatics analysis to disclose shared molecular mechanisms between type-2 diabetes and clear-cell renal-cell carcinoma, and therapeutic indications. | Sci Rep | 2024 | https://conductscience.org/library/papers/39160196 | PubMed |
| 39024368 | In-silico discovery of common molecular signatures for which SARS-CoV-2 infections and lung diseases stimulate each other, and drug repurposing. | PLoS One | 2024 | https://conductscience.org/library/papers/39024368 | PubMed |
| 39005763 | Integrated ML-Based Strategy Identifies Drug Repurposing for Idiopathic Pulmonary Fibrosis. | ACS Omega | 2024 | https://conductscience.org/library/papers/39005763 | PubMed |
| 38001911 | CCR8 as a Therapeutic Novel Target: Omics-Integrated Comprehensive Analysis for Systematically Prioritizing Indications. | Biomedicines | 2023 | https://conductscience.org/library/papers/38001911 | PubMed |
| 37426619 | Virtual high-throughput screening: Potential inhibitors targeting aminopeptidase N (CD13) and PIKfyve for SARS-CoV-2. | Open Life Sci | 2023 | https://conductscience.org/library/papers/37426619 | PubMed |
Genes76
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36949176
GET https://conductscience.org/api/papers/v1/36949176/references?page=2